Abbreviations: IL ϭ interleukin; NE-␣1 PI ϭ neutrophil elastase-␣1 protease inhibitor complex I t is generally accepted that proteases released from neutrophils and/or macrophages are involved in the development of emphysema associated with cigarette smoking. However, it has not been resolved which of these inflammatory cells is the main source of proteases responsible for lung destruction. To address this issue, we compared the concentrations of neutrophil elastase-␣1 protease inhibitor complex (NE-␣1 PI) and cathepsin L in BAL fluid between asymptomatic volunteers aged Ͼ 40 years who had emphysema detected by CT scans and those who had a similar smoking history but did not have emphysema. NE-␣1 PI originates mainly from neutrophils, while cathepsin L is from macrophages. The immunologic levels of both proteases were significantly higher in the subjects with subclinical emphysema; but, when subjects aged Ͻ 60 years were chosen for comparison, there was no difference between the two groups for cathepsin L, although the difference remained for NE-␣1 PI.
I
t is generally accepted that proteases released from neutrophils and/or macrophages are involved in the development of emphysema associated with cigarette smoking. However, it has not been resolved which of these inflammatory cells is the main source of proteases responsible for lung destruction. To address this issue, we compared the concentrations of neutrophil elastase-␣1 protease inhibitor complex (NE-␣1 PI) and cathepsin L in BAL fluid between asymptomatic volunteers aged Ͼ 40 years who had emphysema detected by CT scans and those who had a similar smoking history but did not have emphysema. NE-␣1 PI originates mainly from neutrophils, while cathepsin L is from macrophages. The immunologic levels of both proteases were significantly higher in the subjects with subclinical emphysema; but, when subjects aged Ͻ 60 years were chosen for comparison, there was no difference between the two groups for cathepsin L, although the difference remained for NE-␣1 PI. 1, 2 These results suggested that neutrophils are more important than macrophages in the early development of emphysema. We then used enzyme-linked immunosorbent assays to determine the levels of chemotactic factors for neutrophils and monocytes in BAL fluid. The factors studied were interleukin (IL)-8 and leukotriene B 4 as neutrophil chemoattractants, and monocyte chemotactic protein-1 and macrophage inflammatory protein-1␣ as monocyte chemoattractants. Only the level of IL-8 in BAL fluid among these chemotactic factors had a strong positive correlation with NE-␣1 PI (r ϭ 0.74, p Ͻ 0.01), and was significantly elevated in the subjects with subclinical emphysema (p Ͻ 0.01). To examine the possibility that alveolar macrophages are responsible for the elevation of IL-8 in BAL fluid, we measured IL-8 in alveolar macrophage-conditioned media and alveolar macrophage IL-8 messenger RNA by competitive reverse transcriptasepolymerase chain reaction. We did not, however, find any significant differences between the two groups in these measurements. These studies indicate that neutrophils recruited and/or activated by IL-8 appear to be crucial in the pathogenesis of subclinical emphysema. The source of IL-8 remains to be determined. 
C
igarette smoking causes airway and alveolar inflammation in everyone who smokes and is the major risk factor for developing COPD. However, as only 10 to 15% of heavy smokers develop emphysema and airways obstruction, 1 other risk factors must influence cigarette smoke-induced lung inflammation to cause the lesions that produce COPD. Several factors that add risk to cigarette smoking have been identified, 2 but this brief review is designed to concentrate on lower respiratory tract infections with particular reference to the hypothesis that latent adenoviral infection is capable of amplifying cigarette smokeinduced lung inflammation to produce emphysema.
Acute lower respiratory tract infection (ALRI) in childhood is a major worldwide health problem ranked first among conditions contributing to the global burden of disease. 3 Viral infections contribute about 20 to 30% of all cases of ALRI, 4, 5 and in a community setting, approximately 53.5% of cases of viral etiology are attributable to respiratory syncytial virus (RSV), 13.9% to adenovirus, 7.0% to influenza, 4.7% to parainfluenza, 2.3% to more than one virus. 4 Studies of pediatric hospital admissions for ALRI, on the other hand, show that the proportion of viral infections fall to 36.3% of all cases with RSV, and adenovirus accounting for the bulk of these admissions. 6 An important feature of the adenovirus compared to the other common respiratory viruses is that it has a DNA rather than RNA genome. Portions of this viral DNA persist in host cells after viral replication has stopped as either a circular extra chromosome (plasmid) or by inte-gration into the host DNA. This persistence may be important in the pathogenesis of the known sequelae of adenoviral infection that include the Swyer-James syndrome (or unilateral hyperlucent lung), permanent airways obstruction, bronchiectasis, bronchiolitis obliterans, and steroid-resistant asthma. [7] [8] [9] [10] [11] [12] Our working hypothesis that this latent adenoviral infection also plays a role in the pathogenesis of COPD, because a protein expressed by the latent viral DNA amplifies the expression of genes that are activated in cigarette smoke-induced airway inflammation.
The adenoviruses are icosahedral particles that are 70 to 100 nm in diameter that consist of a protein shell surrounding a double-stranded DNA core. 13 The genomes of Ͼ100 types isolated so far have the same general features, in that they consist of approximately 35 ϫ 10 4 base pairs that contain two origins for DNA replication, five early transcription units, two delayed early units, and one major late unit that is processed to generate five different families of messenger RNA. 14 The replication of the adenovirus is dependent on transcriptional activation that is initiated by activation proteins encoded by one of the early transcription units referred to as the E1A gene. 15, 16 During an acute infection, interactions between the adenoviral E1A protein and host transcriptional elements create conditions that are favorable to viral replication. For example, they induce quiescent cells to enter the S phase of the cell cycle and inhibit host cell apoptosis. 14 They also increase the transcription of viral and host genes by interacting with the DNA binding sites of host transcription factors. 14 Early studies using classical hybridization techniques showed that the viral DNA remained in tonsils 16, 17 and peripheral blood lymphocytes 18 long after viral replication stopped. Polymerase chain reaction based studies have shown that the adenoviral DNA from the E1A gene is present in human lungs, 19 and immunohistochemistry has shown that E1A protein can be demonstrated in epithelial cells on the surface of conducting airways, epithelial glands, and in type II alveolar cells. 20 The essence of our working hypothesis concerning latent adenoviral infection in emphysema is that the E1A protein in alveolar epithelium amplifies the transcription of host genes expressed during cigarette smoke-induced lung inflammation and increases the migration of inflammatory cells into the alveolar surface.
The opportunity to study lung tissue from a group of children who died of ALRI of proven adenovirus etiology using in situ hybridization showed that the virus targets epithelial cells in both the conducting airways and the gas exchanging surface of the lung where it primarily infected the type II cells. 21 In the normal lung, the type II cells cover approximately 7% of the alveolar surface, produce surfactant, and are the progenitors of the type I cell that cover the remaining 93%. 22 The recognition that inflammatory cells migrate out of vessels and into the alveolar airspace by passing between the type I and type II cells 23 puts the type II cell in an ideal position to influence the inflammatory response in alveolar tissue (Fig 1) . Over the past 11 years, we have conducted experiments to determine if the persistence of latent adenoviral infection in lung epithelial cells might amplify cigarette smoke-induced alveolar inflammation.
The demonstration of more E1A DNA in lung tissue from patients with COPD than in tissue from age-and gender-matched control subjects with similar smoking histories 19 and the immunohistochemical studies showing that there was E1A protein in airway surface epithelial cells in epithelial glands and in type II cells on the gas exchanging surface of the lung, 22 encouraged us to initiate an in vitro investigation of a type II-like A549 cell. 24, 25 The A549 cell line is derived from a peripheral lung carcinoma that has many type II cell characteristics. When these cells are transfected with E1A DNA, they demonstrate lamellar bodies and tight junctions consistent with a type II alveolar cell phenotype, 24 and when challenged with inflammatory stimuli, they produce excess interleukin (IL)-8 and intercellular adhesion molecule (ICAM)-1. 29, 30 Subsequent studies demonstrated that the presence of E1A protein leads to the activation of nuclear factor B 26 to initiate these changes, 27 and very recent studies have shown that the excess ICAM-1 and IL-8 production induced by tumor necrosis factor-␣ becomes steroid resistant in E1A transfected cells. 28 The observations suggest that latent adenoviral infection of type II cells in situ might provide a mechanism that could amplify cigarette smoke-induced lung inflammation and make it steroid resistant.
When guinea pigs are exposed to cigarette smoke, they develop lung inflammation involving both the conducting airways and gas exchanging surface, 29, 30 and chronic exposure produces lesions consistent with human emphysema. 31 When guinea pigs with latent adenoviral infection 32 Figure 1 . This drawing from Walker et al 23 illustrates the migratory pathway of polymorphonuclear neutrophils as they pass from the lumen of the pulmonary capillary through the alveolar surface. Walker et al 23 have shown that this migration is not random, in that the cells press through junctional pores that exist where three endothelial cells meet, migrate through existing holes in the endothelial basement membrane, use fibroblasts in the interstitium to guide them to the epithelial basement membrane where they migrate through existing holes, and enter the alveolar compartment between type I and type II cells. The essence of our hypothesis is that latent adenoviral infection in type II cells can amplify the migratory process. AL ϭ alveolar airspace; Cl ϭ capillary lumen; En ϭ endothelium; T1 ϭ type 1 cell; T2 ϭ type 2 cell; P ϭ pore; I ϭ interstitium. Reproduced with permission, Walker et al. 23 are exposed to a single dose of cigarette smoke, they develop an excess inflammatory response 33 that could lead to excess emphysema. In a recent collaboration with the University of Pittsburgh, we compared tissue from patients with mild disease obtained by lung resection for tumor to advanced disease obtained from patients undergoing lung volume reduction surgery. Our preliminary findings suggest that there is a greater inflammatory response in the lung in advanced emphysema that is associated with a greater prevalence of E1A protein in the type II alveolar cell. 34 Collectively, these animal and human studies suggest that advanced emphysema is associated with amplification of the cigarette smoke-induced inflammation, and that this excessive response to cigarettes is related to the presence of latent adenoviral infection.
In summary, the cigarette smoking habit is the numberone risk factor for the development of emphysema and chronic airways obstruction, but only 15 to 20% of heavy smokers develop this complication. 1 Lower respiratory tract infection is one of the factors that contribute to the risk of developing COPD, and our studies of latent adenoviral infection suggest mechanisms by which latent adenoviral infection results in amplification of cigarette smoke-induced lung inflammation. Although the studies presented here have focused on adenovirus, the field is open to the possibility that other infectious agents might produce similar results.
